Detection of genetic mutations underlying early-onset systemic lupus erythematosus

Abstract

Objective

We aimed to investigate the presence of monogenic causes of systemic lupus erythematosus (SLE) in our early-onset SLE patients.

Methods

Fifteen pediatric SLE cases who had early disease onset (≤6 years) were enrolled in this study. All patients fulfilled the Systemic Lupus International Collaborating Clinics (SLICC) criteria. Genomic DNA was used for whole exome sequencing (WES). Pathogenic variants were confirmed by Sanger sequencing.

Results

The median age at diagnosis of 15 early-onset SLE patients included in the study was 4 (2-6) years (F/M = 12/3). Significant gene mutations were detected in five of these patients (33.3%). Patients 1 and 2 with homozygous DNASE1L3 mutations [c.320+4_320+7del and G188 A (c.563 G>C) variants] had skin involvement and oral ulcers. One of them (patient 1) had arthritis and nephritis, and another (patient 2) had nonscarring alopecia and thrombocytopenia. They are currently clinically inactive but have positive serological findings. Patient 3 with homozygous pathogenic ACP5 mutation [G109 R (c.325 G>A) variant] had arthritis, nephritis, short stature, and skeletal dysplasia. Patient 4 with a heterozygote novel IFIH1 mutation [L809 F (c.2425 C>T) variant] had skin findings and leukopenia. Patient 5 with novel C1S variant [homozygous C147 W (c.441 C>G) variant] had marked skin findings, oral ulcers, nonscarring alopecia, pancytopenia, and low total hemolytic complement CH50 level. All patients have responded to the treatments and have low Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores, on therapy.

Conclusion

Genetic causes should be investigated in early-onset SLE, for better management and genetic counseling. On the other hand, multicenter studies may help to further define genotype-phenotype associations.

Keywords

Early-onset genetic mutation monogenic lupus systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Smith

Gordon

. Systemic lupus erythematosus: clinical presentations. Autoimmun Rev 2010; 10(1): 43–45. DOI: 10.1016/j.autrev.2010.08.016.

Gualtierotti

Biggioggero

Penatti

, et al. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010; 10(1): 3–7. DOI: 10.1016/j.autrev.2010.09.007.

Belot

Cimaz

. Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis. Pediatr Rheumatol Online J 2012; 10(1): 21. DOI: 10.1186/1546-0096-10-21.

Batu

. Monogenic systemic lupus erythematosus: insights in pathophysiology. Rheumatol Int 2018; 38(10): 1763–1775. DOI: 10.1007/s00296-018-4048-7.

Demirkaya

Sahin

Romano

, et al. New Horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J Clin Med 2020; 9(3): 712. DOI: 10.3390/jcm9030712.

Truedsson

Bengtsson

Sturfelt

. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007; 40(8): 560–566. DOI: 10.1080/08916930701510673.

Bryan

. Complement deficiencies in systemic lupus erythematosus. Curr Allergy Asthma Rep 2014; 14(7): 448. DOI: 10.1007/s11882-014-0448-2.

Ellyard

Jerjen

Martin

, et al. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing. Arthritis Rheumatol 2014; 66(12): 3382–3386. DOI: 10.1002/art.38824.

Günther

Kind

Reijns

, et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest 2015; 125(1): 413–424. DOI: 10.1172/JCI78001.

10.

Hagberg

Rönnblom

. Systemic lupus erythematosus–a disease with a dysregulated type I interferon system. Scand J Immunol 2015; 82(3): 199–207. DOI: 10.1111/sji.12330.

11.

. Monogenic lupus. Curr Rheumatol Rep 2016; 18(12): 71. DOI: 10.1007/s11926-016-0621-9.

12.

Petri

Orbai

Alarcón

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64(8): 2677–2686. DOI: 10.1002/art.34473.

13.

Gladman

Ginzler

Goldsmith

, et al. The development and initial validation of the systemic lupus international collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39(3): 363–369. DOI: 10.1002/art.1780390303.

14.

Gladman

Ibanez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288–291.

15.

Chan

RWY

Serpas

, et al. Plasma DNA Profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction. Am J Hum Genet 2020; 107(5): 882–894. DOI: 10.1016/j.ajhg.2020.09.006.

16.

Ramesh

Parthasarathy

Janckila

, et al. Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia. PLoS One 2020; 15(3): e0230052. DOI: 10.1371/journal.pone.0230052.

17.

Stegert

Bock

Trendelenburg

. Clinical presentation of human C1q deficiency: How much of a lupus? Mol Immunol 2015; 67(1): 3–11. DOI: 10.1016/j.molimm.2015.03.007.

18.

Batu

Koşukcu

Taşkıran

, et al. Whole exome sequencing in early-onset systemic lupus erythematosus. J Rheumatol 2018; 45(12): 1671–1679. DOI: 10.3899/jrheum.171358.

19.

Ozçakar

Foster

2nd Diaz-Horta

, et al. DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 2013; 65(8): 2183–2189. DOI: 10.1002/art.38010.

20.

Gezgin Yıldırım

Bakkaloğlu

. Monogenic lupus caused by mutations in DNASE1L3: a rare cause of systemic lupus erythematosus in children. Scand J Immunol 2022; 95(6): e13162. DOI: 10.1111/sji.13162.

21.

Al-Mayouf

Sunker

Abdwani

, et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011; 43(12): 1186–1188. DOI: 10.1038/ng.975.

22.

Kisla Ekinci

Balci

Ozcan

, et al. Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis. Eur J Med Genet 2021; 64(9): 104262. DOI: 10.1016/j.ejmg.2021.104262.

23.

Alperin

Ortiz-Fernández

Sawalha

. Monogenic lupus: a developing Paradigm of disease. Front Immunol 2018; 9: 2496. DOI: 10.3389/fimmu.2018.02496.

24.

Dasdemir

Yildiz

Celebi

, et al. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel. Lupus 2022; 31(3): 330–337.

25.

d'Angelo

Di Filippo

Breda

, et al. Type I interferonopathies in children: an Overview. Front Pediatr 2021; 9: 631329. DOI: 10.3389/fped.2021.631329.

26.

Briggs

Rice

Daly

, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011; 43(2): 127–131. DOI: 10.1038/ng.748.